Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-06-11T23:30:26.251Z Has data issue: false hasContentIssue false

10 - Physician–Pharmaceutical Industry Interactions (PPIIs), the Law and the Media

Published online by Cambridge University Press:  03 March 2010

Shaili Jain
Affiliation:
Aurora Medical Group, Milwaukee, Wisconsin
Get access

Summary

Jack left the faculty meeting and headed to clinic. He was not looking forward to his next patient, Mrs. Allison. She was a middle-aged woman with poorly controlled hypertension and Type II diabetes. She had been seen by a string of physicians before him and tried on several different medications. She always left Jack feeling a little frustrated, as she spent more than the allotted appointment time complaining about medication side effects and how “no one was helping her,” yet she had questionable compliance with her medication regime and had not lost weight as he had strongly recommended many months ago.

The debate about the nature of the relationship between the medical profession and the pharmaceutical industry (PI) is a very public one. The negative aspects of the relationship have come under intense criticism in major national newspapers. Such articles have originated from a variety of sources, from medical school faculty as well as journalists. Faculty have publicly highlighted concerns over the influence of PI on medical trainees' prescribing behavior, as well as over the influence of PI on physicians through industry sponsorship of CME, free gifts and food.

With the PI consistently topping the list of the most profitable industries in the United States, its practices have come under much scrutiny in the past several years.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Shapiro D. Drug companies get too close for medical school's comfort. http://query.nytimes.com/gst/fullpage.html?res=9F00E2D81439F933A15752C0A9629C8B63&sec=health&pagewanted=2 Last accessed 12/2006
Relman AS. Your doctor's drug problem. http://www.dearshrink.com/nytimes_docsdrugprob111803.pdf. Last accessed 12/2006
Napoli, M. Drug industry most profitable. Health Facts 2002; 27(5):31/4PGoogle Scholar
Wadman, M. Spitzer sues drug giant for deceiving doctors. Nature 2004; 429(10):589CrossRefGoogle ScholarPubMed
Harris, G. Pfizer to pay $420 million in illegal marketing case. The New York Times. May 14, 2004. Page C6Google Scholar
Kowalcyzk, L. Pfizer unit agrees to $430 million in fines. Boston Globe. May 14, 2001. Page D1Google Scholar
Yamey, G. Eli Lilly violates patients' privacy. BMJ 2001; 323(7304):65CrossRefGoogle Scholar
Harris, G. Drug makers are still giving gifts to doctors, FDA officials tell senators. The New York Times. March 4, 2005. Page A15Google Scholar
Hensley, S, Martinez, B. To sell their drugs, companies increasingly rely on doctors. Wall Street Journal. July 15, 2005. Pages A1, A2Google Scholar
Beatty, Y. Gifts from pharmaceutical representatives: Exercise caution. Tenn Med 2005; 981(1):33–4Google Scholar
Robinson, D J. Interactions between drug reps and physicians. Physicians News Digest 2004 (April):1–3Google Scholar
Studdert, D M, Mello, M M, Brennan, T A. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry – self regulation in the shadow of federal prosecution. N Engl J Med 2004; 351(18):1891–900CrossRefGoogle ScholarPubMed
Tsai, A C. Policies to regulate gifts to physicians from the industry. JAMA 2003; 290(13):1776CrossRefGoogle Scholar
Litman, M, Sheremeta, L. The report of the Committee of Inquiry on the case involving Dr. Nancy Olivieri: A fiduciary law perspective. Health Law Rev 2002; 10(2):3–13Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×